BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28988189)

  • 1. Recurrent chylothorax: a clinical mystery.
    Otoupalova E; Meka SG; Dogra S; Dalal B
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28988189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of chylothorax and direct pleura involvement in a case of Waldenström's macroglobulinaemia.
    Poisson J; Aregui A; Darnige L; Maley K; Gisselbrecht M
    Age Ageing; 2014 Jul; 43(4):581-3. PubMed ID: 24855112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chylothorax as a complication of Waldenström macroglobulinaemia with a patient's perspective.
    Gary P; Gianniosis M; Ryu J; Flynn S
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33962927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylous pleural effusion as the initial manifestation of Waldenström's macroglobulinemia.
    Monteagudo M; Lima J; Garcia-Bragado F; Alvarez J
    Eur J Respir Dis; 1987 May; 70(5):326-7. PubMed ID: 3111875
    [No Abstract]   [Full Text] [Related]  

  • 5. Chylothorax as Rare Manifestation of Pleural Involvement in Waldenström Macroglobulinemia: Mechanisms and Management.
    Leoncini G; Campisi CC; Fraternali Orcioni G; Patrone F; Ferrando F; Campisi C
    Lymphology; 2016 Dec; 49(4):210-17. PubMed ID: 29908554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylothorax as a complication of Waldenström's disease.
    Rizzo S; Campagnoli M
    Eur J Respir Dis; 1984 Jul; 65(5):371-2. PubMed ID: 6430712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diffuse large cell lymphoma and colon adenocarcinoma in patient with Waldenström's macroglobulinaemia].
    Radojković M; Ristić S; Colović N; Cemerikić-Martinović V; Colović M
    Srp Arh Celok Lek; 2011; 139(1-2):95-8. PubMed ID: 21568089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare case of Bing-Neel syndrome treated successfully with ibrutinib.
    Hashmi H; Dhanoa JS; Emmons R
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31243026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chylothorax as the initial manifestation of Waldenström's macroglobulinemia].
    Martí JM; Cervantes F; Lloberes P; Cañete JD; Picado C; Rozman C
    Med Clin (Barc); 1987 Apr; 88(15):591-3. PubMed ID: 3110510
    [No Abstract]   [Full Text] [Related]  

  • 11. [Waldenström macroglobulinemia complicated with chylothorax].
    Misaki S; Sakoda H; Hakata S; Shigematsu M; Hoshida Y
    Rinsho Ketsueki; 2012 Nov; 53(11):1916-20. PubMed ID: 23257673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical nontraumatic chylothorax in a monoclonal IgM elevated nodal marginal zone lymphoma: A case report and review of the literature.
    Wang L; Huang Q; Tang J; Feng J; Huang Y; Dong J; Cheng Y; Xu H; Miao Y
    Front Immunol; 2022; 13():1031122. PubMed ID: 36389754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia.
    Gustine JN; Meid K; Hunter ZR; Xu L; Treon SP; Castillo JJ
    Br J Haematol; 2018 Feb; 180(4):578-581. PubMed ID: 27748515
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
    Talaulikar D; Tam CS; Joshua D; Ho JP; Szer J; Quach H; Spencer A; Harrison S; Mollee P; Roberts AW; Horvath N; Lee C; Zannettino A; Brown R; Augustson B; Jaksic W; Gibson J; Kalff A; Johnston A; Trotman J; Kalro A; Grigoriadis G; Ward C; Prince HM
    Intern Med J; 2017 Jan; 47(1):35-49. PubMed ID: 28076910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibrutinib for the treatment of Waldenström macroglobulinemia.
    Chakraborty R; Kapoor P; Ansell SM; Gertz MA
    Expert Rev Hematol; 2015 Oct; 8(5):569-79. PubMed ID: 26138997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibrutinib in pretreated Waldenström's macroglobulinaemia.
    Bagcchi S
    Lancet Oncol; 2015 May; 16(5):e204. PubMed ID: 25892147
    [No Abstract]   [Full Text] [Related]  

  • 17. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
    Amin CJ; Rabinowitz I
    Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chylothorax complicating Waldenström macroglobulinemia].
    Antón Aranda E
    Arch Bronconeumol; 2001 Mar; 37(3):155-6. PubMed ID: 11333546
    [No Abstract]   [Full Text] [Related]  

  • 19. Updates in prognostication and treatment of Waldenström's macroglobulinemia.
    Advani P; Paulus A; Ailawadhi S
    Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):179-188. PubMed ID: 31158330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent pleural effusion in Waldenström's macroglobulinaemia.
    Teo SK; Lee SK
    Br Med J; 1978 Aug; 2(6137):607-8. PubMed ID: 100164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.